Hepatitis C News and Research

Latest Hepatitis C News and Research

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

Cancer is the second leading cause of death in New York State after heart disease among adults and the second cause of death among children after injuries. And the number of people diagnosed with the disease increases every year.

2 Nov 2021

End-stage renal disease negatively impacts COVID-19 vaccine response

Researchers perform a systematic review of people with end-stage kidney disease receiving SARS-CoV-2 vaccines to assess their immunogenicity rates.

2 Nov 2021

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

The researchers investigated the neutralizing activity of turmeric root extract, curcumin-containing capsules, and pure curcumin against SARS-CoV-2.

1 Nov 2021

Study analyzes the financial burden of chronic hepatitis C on Ontario patients

Ontarians with chronic hepatitis C can lose up to 20 per cent of their overall income managing their condition, a new study has found.

1 Nov 2021

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

29 Oct 2021

Study focuses on the high hepatitis C rates in pregnant people

Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their babies.

29 Oct 2021

Third dose of Covid-19 vaccine benefits dialysis patients

In some patients, the immune system responds poorly to the second vaccination dose. This changes with the third shot.

28 Oct 2021

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

A new study identifies a potent SARS-CoV-2 antiviral, Pheophorbide a (PheoA), which is a compound derived from the plant Marchantia polymorpha L.

27 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

Study finds significant surge in liver transplantation for alcoholic hepatitis during the pandemic

Registrations for the national organ transplant waiting list related to alcoholic hepatitis as well as the number of deceased donor liver transplants for the inflammatory liver condition rose significantly during the pandemic, Michigan Medicine researchers found.

26 Oct 2021

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

A new study examines the potential binding interaction of the beneficial components of Chaga mushroom with that of the SARS-CoV-2 RBD.

24 Oct 2021

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.

21 Oct 2021

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.

19 Oct 2021

The biochemical mechanisms of remdesivir-mediated RNA synthesis inhibition

A new preprint suggests a fruitful approach to develop such drugs based on biochemical and molecular modeling studies of the drug remdesivir.

19 Oct 2021

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

15 Oct 2021

Hepatitis C News and Research

Latest Hepatitis C News and Research

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

End-stage renal disease negatively impacts COVID-19 vaccine response

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

Study analyzes the financial burden of chronic hepatitis C on Ontario patients

New evidence that SARS-CoV-2 virus can infect the inner ear

Study focuses on the high hepatitis C rates in pregnant people

Third dose of Covid-19 vaccine benefits dialysis patients

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Study finds significant surge in liver transplantation for alcoholic hepatitis during the pandemic

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

The biochemical mechanisms of remdesivir-mediated RNA synthesis inhibition

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

Study reveals the zoonotic potential of the rat Sialodacryoadenitis virus

New high-throughput assay could help development of anti-COVID-19 drugs

Study identifies DNA mutations linking liver disease with obesity and diabetes

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

Study identifies hotspots for opioid overdose and other drug-related disorders

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Hepatitis C News and Research

Latest Hepatitis C News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in